Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1974-7-16
|
pubmed:language |
rum
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0028-386X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
559-68
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:4790488-Adult,
pubmed-meshheading:4790488-Aged,
pubmed-meshheading:4790488-Amantadine,
pubmed-meshheading:4790488-Dihydroxyphenylalanine,
pubmed-meshheading:4790488-Drug Therapy, Combination,
pubmed-meshheading:4790488-Female,
pubmed-meshheading:4790488-Humans,
pubmed-meshheading:4790488-Male,
pubmed-meshheading:4790488-Middle Aged,
pubmed-meshheading:4790488-Parkinson Disease, Secondary
|
pubmed:articleTitle |
[Treatment of the parkinsonian syndrome with L-dopa and amantadine].
|
pubmed:publicationType |
Journal Article
|